|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
Markus Sieger
|
|
gptkbp:country
|
gptkb:Poland
|
|
gptkbp:focusArea
|
cardiology
immunology
infectious diseases
neurology
gastroenterology
ophthalmology
diabetology
|
|
gptkbp:founded
|
1935
|
|
gptkbp:hasResearchCenter
|
gptkb:Kazakhstan
gptkb:Poland
gptkb:Russia
|
|
gptkbp:headquarters_location
|
gptkb:Starogard_Gdański
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Polpharma
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:manufacturingFacilities
|
gptkb:Belarus
gptkb:Kazakhstan
gptkb:Poland
gptkb:Russia
gptkb:Uzbekistan
|
|
gptkbp:market
|
gptkb:Asia
gptkb:Europe
gptkb:CIS_countries
over 60 countries
|
|
gptkbp:member
|
Polpharma Group
|
|
gptkbp:notableProduct
|
Acard
Amlozek
Bioprazol
Enarenal
Etopiryna
Furosemidum Polpharma
Metocard
Polocard
Tertens-AM
Tertens-AM SR
Tertensif
Tertensif SR
|
|
gptkbp:numberOfEmployees
|
over 7,500
|
|
gptkbp:parentOrganization
|
Polpharma Group
|
|
gptkbp:products
|
generic drugs
active pharmaceutical ingredients
|
|
gptkbp:revenue
|
over 1 billion EUR (approximate, 2022)
|
|
gptkbp:stockExchange
|
not publicly listed
|
|
gptkbp:subsidiary
|
Akrikhin
Chimpharm
Polfa Warszawa
|
|
gptkbp:website
|
https://www.polpharma.pl/
|
|
gptkbp:bfsParent
|
gptkb:Polpharma_Starogard_Gdański
gptkb:Jerzy_Woźniak-Starak
|
|
gptkbp:bfsLayer
|
7
|